Connect Biopharma Holdings Ltd (CNTB) Research And Development Expense USD 2021 - 2022

Historical data

Taxonomy & unit
ifrs-full: CNY and USD
Summary
Connect Biopharma Holdings Ltd annual Research And Development Expense history and growth rate from 2021 to 2022.
  • Connect Biopharma Holdings Ltd annual Research And Development Expense for 2022 was $93.6 M, a 15.3% increase from 2021.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $93.6 M +$12.4 M +15.3% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-11
2021 $81.2 M Jan 1, 2021 Dec 31, 2021 20-F 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.